Keywords: huntingdon, study, offers, hope, slowing, disease, progression

Huntingdon study offers hope of slowing disease progression

Article | 22 August 2001

Print This

A study in the USA and Canada which compared Vitaline's novelformulation of Co-enzyme Q10 and AstraZeneca's remacemide as a treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in